Cargando…
Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease
Alzheimer’s disease (AD)—a complex disease showing multiple pathomechanistic alterations—is triggered by nonlinear dynamic interactions of genetic/epigenetic and environmental risk factors, which, ultimately, converge into a biologically heterogeneous disease. To tackle the burden of AD during early...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787542/ https://www.ncbi.nlm.nih.gov/pubmed/31636492 http://dx.doi.org/10.31887/DCNS.2019.21.2/hhampel |